Related Experiment Video
Updated: Jan 20, 2026

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
Published on: January 31, 2017
Expressive Flexibility as a Buffer in the Association Between Substance Use Stigma and Drug Use Problems Among
Katie Wang1, Rachel Girard2, Robert B Manning3
1Department of Social and Behavioral Sciences, Yale School of Public Health.
Abstract:
Prior research has linked stigma associated with substance use (e.g., encounters with and anticipation of discrimination, internalization of negative stereotypes) to increased drug use problems, yet little work has examined protective factors that mitigate this association. The current study examined expressive flexibility (i.e., the ability to flexibly enhance and suppress one's emotional expression in accordance with situational demands), an important component of emotion regulation and psychological flexibility, as a buffer in the relation between substance use stigma and drug use problems among individuals with depression, a population disproportionately impacted by substance use disorder. A community sample of U.S. adults diagnosed with major depressive disorder (N = 112) completed self-report measures of substance use stigma, expressive flexibility, and drug use problems. Moderation analyses showed that substance use stigma was significantly associated with drug use problems, but the association was attenuated for participants with high levels of expressive flexibility. These findings underscored the potential utility of fostering expressive flexibility as a stigma coping resource in substance use prevention and treatment interventions.
Related Concept Videos
Deleterious Substances in Aggregate
Another type of impurity is clay and fine material that...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
06:41Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
08:49Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:18A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
Connective Tissue Fibers and Ground Substance

